前蛋白转化酶枯草溶菌素9及其单克隆抗体调脂研究进展
PCSK9 and monoclonal antibody inhibitors of PCSK9: focus on lipid management
摘要
2003年，法国学者Abifadel等首次报道前蛋白转化酶枯草溶菌素9（proproteinconveasesubtilisin／kexintype9，PCSK9）基因突变引起常染色体显性高胆固醇血症（autosomaldominanthypercholester0Iemia，ADH）。
出处
《中国心血管杂志》
2013年第6期473-476,共4页
Chinese Journal of Cardiovascular Medicine
关键词
前蛋白转化酶枯草溶菌素9
受体
LDL
血脂异常
抗体
单克隆
Proprotein convertase subtilisin/kexin type 9
Receptors, LDL
Dyslipidemias
Antibodies, monoclonal
参考文献27
-
1Abifadel M,Varret M, Rabbs JP, et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet, 2003, 34: 154-156.
-
2Lambert G, Charhon F, Rye KA, et al. Molecular basis of PCSK9 function. Atherosclerosis, 2009, 203 : 1-7.
-
3I-Iumphries SE, Neely RD, Whittall RA, et al. Healthy individuals carrying the PCSK9 p. R46L variant and familial hypercholesterolemia patients carrying PCSK9 p. D374Y exhibit lower plasma concentrations of PCSKg. Clin Cbem, 2009, 55: 2153-2161.
-
4Cohen JC, Boerwinkle E, Mosley TH Jr, et al. Sequence variations in PCSKP, low LDL, and protection against coronary heart disease. N Engl J Med, 2006, 354: 1264-1272.
-
5Cariou B, Le May C, Costet P. Clinical aspects of PCSK9. Atherosclerosis, 2011, 216: 258-265.
-
6Seidah NG, Benjannet S, Wickham L, et al. The secretory proproteinconvertase neural apoptosis-regulated convertase 1 ( NARC-1 ) : liver regeneration and neuronal differentiation. Proc Natl Acad Sci U S A, 2003, 100: 928-933.
-
7Piper DE, Jackson S, Liu Q, et al. The crystal structure of PCSK9 : a regulator of plasma LDL-cholesterol. Structure, 2007, 15 : 545-552.
-
8Maxwell KN, Breslow JL. Adenoviral-mediated expression of Pesk9 in mice results in a low-density lipoprotein receptor knockout phenotype. Proe Natl Aead Sci U S A, 2004, 101: 7100-7105.
-
9Fisher TS,Lo Surdo P, Pandit S, et al. Effects of pH and low density lipoproteln (LDL) on PCSK9-dependent LDL receptor regulation. J Biol Chem, 2007, 282: 20502-20512.
-
10Yamamoto T,Lu C, Ryan RO. A two-step binding model of.PCSK9 interaction with the low density lipoprotein receptor. J Biol Chem, 2011, 286 : 5464-5470.
-
1崔琴,俞丹,鞠现霞,王坤林,常毅娜,曹国庆,杨涛,周红文.前蛋白转化酶枯草溶菌素9对胆固醇水平的影响[J].江苏医药,2010,36(24):2880-2882.
-
2苏婷,张盼晓,王志禄.前蛋白转化酶枯草溶菌素9抑制剂:阿利库单抗的研究进展[J].心血管病学进展,2016,37(1):78-81.
-
3李延海,田针针,卢清军,任鹏.人前蛋白转化酶枯草溶菌素9型在大肠癌中的表达及意义[J].中华实验外科杂志,2016,33(1):62-62. 被引量：1
-
4王梅,李艳芳.前蛋白转化酶枯草溶菌素9相关影响因素及其抑制剂的研究进展[J].中华老年心脑血管病杂志,2016,18(5):549-550. 被引量：2
-
5余凌,许如意,杨晔,叶平.调脂新药前蛋白转化酶枯草溶菌素9抑制剂的研究进展[J].中华老年心脑血管病杂志,2014,16(5):547-549. 被引量：1
-
6王配配（摘译）.腹型肥胖在肺功能损害和代谢综合征中的重要作用[J].中华医学信息导报,2009,24(7):13-13.
-
7边吃边谈有益于健康[J].发现,2002,0(9):45-45.
-
8王艳,韩颖.枯草溶菌素转换酶9与血脂代谢调节[J].国际脑血管病杂志,2009,17(3):211-214.
-
9邱瑜,文红艳.前蛋白转化酶枯草溶菌素9基因与冠心病[J].社区医学杂志,2010,8(1):37-38.
-
10王世斌.别让胸罩变“凶罩”[J].医药与保健,2013(6):38-38.
